CIK 0001799191 · Accelerated filer<br>Smaller reporting company
Starling Oncology, Inc.
Sign in to watch- Tickers
- STLN DFPH
- Exchange
- Nasdaq, OTC
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 843562323
- Phone
- 562-735-3226
- Business address
- 18000 STUDEBAKER RD, SUITE 800, CERRITOS, CA, 90703
- Former names
- Oncology Institute, Inc., DFP HEALTHCARE ACQUISITIONS CORP.
Securities
- STLN Common Stock Nasdaq
- STLNW Warrant Nasdaq
- DFPH Common stock OTC
- Open-market buys, last 90 days
- $176,273
- in 1 filing
- Open-market sales, last 90 days
- $13,322,043
- in 2 filings, $1.9M under 10b5-1 plans
Net −$13,145,770. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-14 | Podnos Yale Chief Medical Officer | Option exercise 10b5-1 | +5,478 | $2.00 | $11K | 265,005 |
| 2026-07-14 | Podnos Yale Chief Medical Officer | Sale 10b5-1 | −5,478 | $6.35 | $35K | 259,527 |
| 2026-07-14 | Podnos Yale Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | +17,974 | $1.87 | $34K | 0 |
| 2026-07-14 | Podnos Yale Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | +5,478 | $2.00 | $11K | 0 |
| 2026-07-10 | Chernett Jorey 10% owner | Purchase | +15,000 | $5.85 | $88K | 10,630,858 |
| 2026-07-07 | TZOUMAKAS KIMBERLY JO Director | Grant or award | +17,185 | 17,185 | ||
| 2026-07-07 | STOLPER MARK Director | Grant or award | +25,833 | 25,833 | ||
| 2026-06-23 | Chernett Jorey 10% owner | Purchase | +18,000 | $5.02 | $90K | 10,615,858 |
| 2026-06-08 | Podnos Yale Chief Medical Officer | Sale 10b5-1 | −23,451 | $5.38 | $126K | 259,527 |
| 2026-06-04 | Chernett Jorey 10% owner | Purchase | +12,000 | $4.75 | $57K | 10,579,858 |
| 2026-05-21 | Podnos Yale Chief Medical Officer | Other disposition | −1,805 | $4.47 | $8K | 282,978 |
| 2026-05-21 | Virnich Daniel Chief Executive Officer | Other disposition | −23,058 | $4.47 | $103K | 2,337,166 |
| 2026-05-21 | Carter Robert Ross Chief Financial Officer | Other disposition | −1,604 | $4.47 | $7K | 414,801 |
| 2026-05-20 | Chernett Jorey 10% owner | Purchase | +33,500 | $4.07 | $136K | 10,567,858 |
| 2026-05-19 | Chernett Jorey 10% owner | Purchase | +5,000 | $4.05 | $20K | 10,534,358 |
| 2026-05-19 | Chernett Jorey 10% owner | Purchase | +30,000 | $4.09 | $123K | 10,529,358 |
| 2026-04-16 | Kaushal Mohit Director | Sale 10b5-1 | −38,433 | $3.50 | $135K | 172,583 |
| 2026-04-14 | Kaushal Mohit Director | Sale 10b5-1 | −57,286 | $3.50 | $201K | 211,016 |
| 2026-04-09 | Chernett Jorey 10% owner | Purchase | +20,000 | $3.10 | $62K | 10,499,358 |
| 2026-03-27 | Langsam Jeffrey Chief Clinical Officer | Grant or award | +70,270 | 127,650 |
Page 2 of 8 · 157 trades